Table 1 Clinical and blood pressure characteristics of participants not using blood pressure-lowering lowering medications

From: Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use

 

NT

WH

MH

SH

(n = 194)

(n = 68)

(n = 38)

(n = 154)

Male sex, n (%)

86 (44)

36 (53)

22 (58)

85 (55)

Age, years

42.2 ± 15.6

45.7 ± 16.7

46.8 ± 15.2

47.1 ± 14.5*

Body mass index, k/m2

27.0 ± 4.2

27.6 ± 4.3

27.5 ± 3.3

28.8 ± 11.4

Hypolipemiant med, n (%)

7 (4)

4 (6)

2 (5)

7 (5)

Antidiabetic med, n (%)

8 (4)

3 (4)

0 (0)

8 (5)

Physical activity, n (%)

63 (33)

26 (38)

12 (32)

43 (28)

Current smoking, n (%)

2 (1)

0 (0)

1 (3)

6 (4)

Office SBP, mmHg

120.8 ± 10.3

140.2 ± 12.4*

124.7 ± 10.2

144.5 ± 16.9*

Office DBP, mmHg

77.4 ± 7.6

89.5 ± 8.9*

82.4 ± 7.4*

98.1 ± 10.9*†‡

Office MAP, mmHg

91.9 ± 7.1

106.4 ± 6.0*

96.5 ± 7.5*

113.6 ± 10.3*†‡

24 h SBP, mmHg

113.5 ± 7.7

118.0 ± 6.1*

126.9 ± 9.2*

129.7 ± 9.6*

24 h DBP, mmHg

70.3 ± 5.9

73.6 ± 4.4*

82.1 ± 5.4*

85.8 ± 6.8*†‡

24 h MAP, mmHg

84.7 ± 5.6

88.4 ± 3.6*

97.1 ± 5.0*

100.4 ± 6.6*†‡

Daytime SBP, mmHg

116.3 ± 7.8

121.1 ± 7.4*

130.0 ± 8.8*

133.0 ± 9.3*†

Daytime DBP, mmHg

73.3 ± 6.5

76.4 ± 5.3*

84.9 ± 6.6*

89.1 ± 7.6*†‡

Daytime MAP, mmHg

87.6 ± 6.0

91.3 ± 4.8*

99.9 ± 5.6*

103.7 ± 7.0*†‡

Nighttime SBP, mmHg

108.9 ± 9.2

113.0 ± 7.4

121.2 ± 12.1*

123.2 ± 15.2*

Nighttime DBP, mmHg

65.2 ± 6.8

69.1 ± 5.3*

77.1 ± 6.3*

79.9 ± 8.6*

Nighttime MAP, mmHg

79.8 ± 6.8

83.7 ± 4.9*

91.8 ± 7.2*

94.3 ± 9.5*

  1. DBP diastolic blood pressure, SBP systolic blood pressure, MAP mean arterial pressure, med medications, NT normotension, WH white-coat hypertension, MH masked hypertension, SH sustained hypertension
  2. *P < 0.05 compared with NT; P < 0.05 compared with WH; P < 0.05 compared with MH